| Last Trade: |
81.20 |
| Trade Time: |
May 25 1:52 PM Eastern Daylight Time |
| Change: |
0.00 (0.00 %) |
| Prev Close: |
81.20 |
| Open: |
81.28 |
| Bid: |
81.19 |
| Ask: |
81.20 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
4/18/2012
|
Jorgine Ellerbrock
|
Senior VP, Operations
|
-885
|
$66.00
|
-15.82%
|
|
4/17/2012
|
HULL CARL
|
Chairman and CEO
|
7,083
|
$47.42
|
15.08%
|
|
4/17/2012
|
Jorgine Ellerbrock
|
Senior VP, Operations
|
269
|
$38.51
|
5.05%
|
|
4/17/2012
|
Jorgine Ellerbrock
|
Senior VP, Operations
|
912
|
$42.66
|
20.67%
|
|
4/17/2012
|
HULL CARL
|
Chairman and CEO
|
-1,200
|
$66.65
|
-2.49%
|
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (GPRO), click here.
-
In an attempt to expand its Point of Need diagnostics portfolio, Qiagen (QGEN) recently acquired Boston-based privately owned company AmniSure International. Through the acquisition, Qiagen will ...
Read More »
-
Gen-Probe's EPS and Sales Beat - Analyst Blog
Read More »
-
HOLX / GPRO Deal Could Be Good for CUR - Analyst Blog
Read More »
-
Hologic Incurs Loss, Eyes Gen-Probe - Analyst Blog
Read More »
-
Neogen's valuation makes no sense.
Read More »
Free Reports
|
|
